Back to News

Apogee Therapeutics CMO Carl Dambkowski sells $737,934 in shares

Article content was not available (HTTP 403), so no financial news details could be extracted.

Analysis

Article content was not available (HTTP 403), so no financial news details could be extracted.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

More News